Skip to main content
Log in

Preoperative oral supplementation support in patients with esophageal cancer

  • Published:
The journal of nutrition, health & aging

Abstract

Objective

Surgeries for cancer of the esophagus are still associated with a high rate of postoperative morbidity. There are few reports of perioperative nutritional support for patients undergoing esophageal cancer surgery, and there is insufficient evidence to recommend routine use of immunonutrition in these patients. The aim of this study was to determine whether preoperative immunonutrition positively influences key clinical outcomes such as postoperative infectious complications, mortality, length of hospital stay, and short-term survival in this population.

Design and Setting

We undertook a retrospective investigation of the effects of preoperative nutritional support on the postoperative course of esophageal cancer surgery at the Department of Gastroenterological Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan.

Participants

Fifty-five patients who underwent esophagectomy for esophageal cancer were included in this study. Of the 55 patients, 26 patients consumed a liquid dietary supplement (IMPACT group) before surgery and 29 patients did not (STANDARD group).

Intervention

Before surgery, the IMPACT group consumed 750 ml (3 packs)/day of Impact® for 5 consecutive days.

Measurements

The analysis was based on postoperative complications, hospital mortality, length of hospital stay, and short-term survival.

Results

Significantly fewer patients developed postoperative infections in the IMPACT group compared with the STANDARD group (p=.007): 4 of 21 patients in the IMPACT group and 10 of 29 patients in the STANDARD group. Either an infectious complication or another complication developed in 8 patients in the IMPACT group and 13 patients in the STANDARD group, with the result that 6 patients in the STANDARD group died of postoperative complications (p=.001). The duration of hospitalization was 34 days in the IMPACT group and 48 days in the STANDARD group; hence, hospitalization was significantly shorter in patients treated with Impact® (p=.008). The mean 6-month survival rates for the IMPACT group and the STANDARD group were 92% (24/26) and 72% (21/29), respectively (p=.028).

Conclusion

Simple preoperative supplementation significantly improved outcome. Administration of the supplemental diet before esophageal surgery appeared to be an effective strategy in reducing infectious complications, mortality, and hospitalization, and improving short-term survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Daly JM, Lieberman MD, Goldfine J, Shou J, Weitraub F, Rosato EF, Lavin P (1992) Enteral nutrition with supplemental arginine, RNA, and omega 3 fatty acids in patients after operation. Immunologic, metabolic and clinical outcome. Surgery 112:56–67

    PubMed  CAS  Google Scholar 

  2. Gianotti L, Braga M, Vignali A, Balzano G, Zerbi A, Bisagni P, Di Carlo V (1997) Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasm. Arch Surg 132:1222–1230

    Article  PubMed  CAS  Google Scholar 

  3. Senkal M, Mumme A, Eickhoff U, Geier B, Spath G, Wulfert D, Joosten U, Frei A, Kemen M (1997) Early postoperative immunonutrition: clinical outcome and costcomparison analysis in surgical patients. Crit Care Med 25:1489–1496

    Article  PubMed  CAS  Google Scholar 

  4. Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, Di Carlo V (1999) Perioperative immunonutrition in patients undergoing cancer surgery. Results of a rabdomized double-blind phase 3 trial. Arch Surg 134:428–433

    Article  PubMed  CAS  Google Scholar 

  5. Senkal M, Zumtobei V, Bauer KH, Marpe B, Wolfram G, Frei A, Eickhoff U, Kemen M (1999) Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 134:1309–1316

    Article  PubMed  CAS  Google Scholar 

  6. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V (2002) A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122:1763–1770

    Article  PubMed  CAS  Google Scholar 

  7. Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V (2002) Nutritional approach in malnourished surgical patients. A prospective randomized study. Arch Surg 137:174–180

    Article  PubMed  Google Scholar 

  8. Mudge L, Isenring E, Jamieson GG (2011) Immunonutrition in patients undergoing esophageal cancer resection. Dis Esophagus 24:160–165

    Article  PubMed  CAS  Google Scholar 

  9. Nakamura M, Iwahashi M, Takifuji K, nakamori M, Naka T, Ishida K, Ojima T, Iida T, Katsuda M, hayata K, Yamaue H (2009) Optimal dose of preoperative enteral immunonutrition for patients with esophageal cancer. Surg Today 39:855–860

    Article  PubMed  CAS  Google Scholar 

  10. Takeuchi H, Ikeuchi S, Kawaguchi Y, Kitagawa Y, Isobe Y, Kubochi K, Kitajima M, Matsumoto S (2007) Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg 31:2160–2167

    Article  PubMed  Google Scholar 

  11. Sakurai Y, Masui T, Yoshida I, Tonomura S, Shoji M, Nakamura Y, Isogaki J, Uyama I, Komori Y, Ochiai M (2007) Randomized clinical trial of the effects of perioperative use of immune-enhancing enteral formula on metabolic and immunological status in patients undergoing esophagectomy. World J Surg 31:2150–2157

    Article  PubMed  Google Scholar 

  12. The Japan Esophageal Society (2009) Japanese Classification of Esophageal Cancer, tenth edition: part I. Esophagus 6:1–25

    Article  Google Scholar 

  13. Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5- fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74

    Article  PubMed  Google Scholar 

  14. ASPEN Board of Directors and the Clinical Guidelines Task Force (2002) Guidelines for the use parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr 26:144

    Google Scholar 

  15. American Gastroenterological Association Medical Position Statement (1995) Guidelines for the use of enteral nutrition. Gastroenterology 108:1280–1281

    Article  Google Scholar 

  16. Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M, Twomey B (1997) Nutritional support in clitical practice: review of the published data and recommendation for future directions. J Parenter Enteral Nutr 21:133–156

    Article  CAS  Google Scholar 

  17. Beale RJ, Bryg DJ, Bihari DJ (1999) Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 27:2799–2805

    Article  PubMed  CAS  Google Scholar 

  18. Heys S, Walker LG, Smith I, Eremin O (1999) Enteral nutrition supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 229:467–477

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  19. Braga M, Gianotti L (2005) Preoperative immunonutrition: cost-benefit analysis. J Parenter Enteral Nutr 29:57–61

    Article  Google Scholar 

  20. Miyata H, Yano M, Yasuda T, Hamano R, Yamasaki M, Hou E, Motoori M, Shiraishi O, Tanaka K, Mori M, Doki Y (2012) Randomized study of clinical effect of enteral nutritional support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 31:330–336

    Article  PubMed  Google Scholar 

  21. Gadsby R (2013) Percutaneous endoscopic gastrostomy (PEG) feeding in elderly people with diabetes resident in nursing homes. J Nutr Health Aging 1:16–18

    Article  Google Scholar 

  22. Kimyagarov S, Turgeman D, Fleissig Y, Klid R, Kopel B, Adunsky A (2013) Percutaneous endoscopic gastrostomy (PEG) tube feeding of nursing home residents is not associated with improved body composition parameters. J Nutr Health Aging 2:162–165

    Article  Google Scholar 

  23. Chang CC (2012) Prevalence and factors associated with feeding difficulty in institutionalized elderly with dementia in Taiwan. J Nutr Health Aging 3:258–261

    Article  Google Scholar 

  24. Zaherah Mohamed Shah F, Suraiya HS, Poi PJH, Tan KS, Lai PSM, Ramakrishnan K, Mahadeva S (2012) Long-term nasogastric tube feeding in elderly stroke patients — an assessment of nutritional adequacy and attitudes to gastrostomy feeding in Asians. J Nutr Health Aging 8:701–706

    Article  Google Scholar 

  25. Waitzberg DL, Saito H, Plank LD, Jamieson GG, Jagannath P, Hwang TL, Mijares JM, Bihari D (2006) Postsurgical infections are reduced with specializd nutrition support. World J Surg 30:1592–1604

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keisuke Kubota.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kubota, K., Kuroda, J., Yoshida, M. et al. Preoperative oral supplementation support in patients with esophageal cancer. J Nutr Health Aging 18, 437–440 (2014). https://doi.org/10.1007/s12603-014-0018-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-014-0018-2

Key words

Navigation